APhA’s Pharmacy-Based Cardiovascular Disease Risk Management is an innovative and interactive certificate training program that explores the pharmacist’s role in cardiovascular disease risk management. This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.
How It Works
This program is conducted in two parts:
1) A Web-Based Self-Study
2) Live Training Seminar
A Certificate of Achievement is awarded to participants who successfully complete all activity requirements which include a pre-test, the self-study activity, the self-study assessment, the live training seminar, and the final assessment. Successful completion is defined as:
- Completing the pre-test
- Completing a self-study assessment with a score of 70% or higher
- Attendance at the live seminar
- A final assessment score of 70%
- Completion of the activity evaluation.
Successful completion of the entire program will result in 20 contact hours of CPE credit (2.0 CEU).
Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 12 contact hours of CPE credits (1.2 CEUs).
ACPE UAN: 0202-9999-18-106-H01-P.
Successful completion of the live seminar component involves attending the full live seminar, passing the final assessment with a grade of 70% or higher and completing a skills assessment. Successful completion of this component will result in 8 contact hours of CPE credit (0.80 CEU).
ACPE UAN: 0202-9999-18-107-L01-P.
Once credit is claimed, Statements of Credit will be available online within 24 hours on participant’s CPE Monitor profile at www.nabp.net. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s “My Training” page on www.pharmacist.com.
Activity Type: Practiced Based
Target Audience: Pharmacists in all practice settings and students
Learning Level: 2 — Experience with the topic is recommended, but advanced expertise or specialty practice in the subject area is not necessary. This activity will focus on expanding the learner’s knowledge and application of new and/or more complex information.
APhA’s Pharmacy-Based Cardiovascular Disease Risk Management was developed by the American Pharmacists Association.
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.
- The self-study modules will focus on these core areas:
- Module 1. Cardiovascular Disease Risk Assessment — Assessment of factors that put patients at an increased risk for cardiovascular disease.
- Module 2. Managing Dyslipidenia — Review of pathophysiology, explanation of the recommended approach to treatment, and extensive discussion of pharmacologic options for the management of dyslipidemia.
- Module 3. Managing Hypertension — Review of pathophysiology, explanation of the recommended approach to treatment, and extensive discussion of pharmacologic options for the management of hypertension.
- Module 4. Lifestyle Modifications and Risk Factor Management —Discussion of recommended dietary interventions, physical activity, weight reduction, and smoking cessation.
- Module 5. The Pharmacist’s Role in Cardiovascular Disease Prevention and Management — Explanation of ongoing patient monitoring techniques and communication with prescribers to optimize patient self-management (including adherence and behavior change counseling).
- The live seminar will focus on these core areas:
- A case-based approach to cardiovascular disease risk assessment and treatment decisions, managing special situations, treating hypertension in a patient with diabetes, and lifestyle modifications and motivational interviewing.
- Skills assessments on blood pressure measurement technique and motivational interviewing. Participants will be conducting blood pressure assessments on other participants.
- A discussion regarding the role of the pharmacist and existing business models for cardiovascular disease risk management services.
Course material and exams will be accessed online - In order to participate in this activity, registrants must have access to a computer with minimum system requirements: Internet connectivity with current version of internet browsers, such as Chrome, Firefox, Safari, or Internet Explorer (V8 and above); Adobe Acrobat Reader, Flash Player 8 or higher, Windows 95, Pentium 3 or equivalent processor, 64 MB of free memory (not 64 MB total), and Audio: Sound card and speakers or earphones. CLICK HERE for full technology requirements.
- Educate pharmacists on current evidence-based treatment goals and clinical management recommendations for dyslipidemia and hypertension.
- Familiarize pharmacists with important concepts related to healthful lifestyle changes that focus on cardiovascular disease prevention.
- Introduce techniques and skills for encouraging patient adherence to prescribed therapies.
- Ensure pharmacist proficiency in blood pressure measurement technique and point-of-care lipid testing.
- Enhance pharmacist experience in applying elements of motivational interviewing with respect to medication adherence and lifestyle modifications.
- Morning Session:
- Welcome and Introductions
- Cardiovascular Disease Risk Assessment and Treatment Decisions
- Aspirin for Primary Prevention of ASCVD Events
- Special Considerations for Management of Hypertension and Lipids in Patients with Chronic Kidney Disease or Advanced Age
- Treatment Decisions for Patients with Borderline Risk
- Managing Risks of Statin Therapy
- Hospital Re-admissions
- Lifestyle Modifications
- Lunch and Networking
- Afternoon Session
- Motivational Interviewing
- Motivational Interviewing Activity
- Patient Assessment Skills
- Blood Pressure Measurement Practice
- Business Considerations and Practice Models
- Transitions of Care Patient Case
- Take Home Points, Questions, and Final Instructions